Competitive and Non-Competitive Antagonists

what is an antagonist?

a drug that binds to a receptor but does not activate it, thereby blocking or reducing the effects of an agonist. Antagonists have no intrinsic efficacy and do not produce a biological response on their own.

what are the two main types of antagonists?

competitive antagonists and non-competitive antagonists

what is competitive antagonism?

a type of antagonism in which the antagonist binds reversibly to the same (orthosteric) receptor site as the agonist and competes for receptor occupancy

what is a non-competitive antagonism?

a type of antagonism in which the antagonist binds to the allosteric site or irreversibly binds to the orthosteric site, reducing receptor function and agonistic efficacy

what does “no intrinsic efficacy” mean?

the antagonist does not activate the receptor or produce a biological response when it binds

where do competitive antagonists bind?

at the orthosteric site, which is the same site occupied by the agonist

is competitive antagonist binding usually reversible or irreversible?

reversible (most commonly)

how do competitive antagonists work?

they compete with agonists for receptor occupancy

can increasing agonist concentration overcome competitive antagonism?

yes. increasing the agonist concentration can overcome the antagonism.

where do non-competitive antagonists bind?

at an allosteric site(different from the agonist binding site) or irreversibly at the orthosteric site.

what are the mechanisms of non-competitive agonists?

they either:

1. change receptor conformation and reduce agonist efficacy (allosteric)

2. permanently inactivate receptors(irreversible)

can increasing agonist concentration overcome non-competitive antagonism?

no. non-competitive antagonism cannot be overcome by increasing agonist concentration

how does ketamine act as a non-competitive antagonist?

Ketamine binds within the NMDA receptor channel at a site distinct from the glutamate binding site, blocking ion flow and inhibiting excitatory neurotransmission regardless of glutamate concentration.

how does a competitive antagonist affect an agonist dose-response curve?

it causes a parallel rightward shift curve

what happens to Emax with a competitive antagonist?

Emax remains unchanged

what happens to agonist potency in the presence of a competitive antagonist?

potency decreases, resulting in an increased EC50

What happens to EC50 with a competitive antagonist?

EC50 increases

how does a non-competitive antagonist effect a dose-response curve?

it produces a non-parallel shift and decreases the maximal response

what happens to Emax with a non-competitive antagonist?

Emax decreases

What happens to EC50 with a non-competitive antagonist?

EC50 may or may not change.

What dose-response curve pattern is most characteristic of competitive antagonism?

Parallel rightward shift with unchanged Emax.

What dose-response curve pattern is most characteristic of non-competitive antagonism?

Downward reduction in Emax that cannot be overcome by increasing agonist concentration.

Give three examples of competitive antagonists.

Atropine, naloxone, and propranolol.

Give three examples of non-competitive antagonists.

Phenoxybenzamine, ketamine, and aspirin.

Why are competitive antagonists useful clinically?

Their effects are reversible with higher agonist doses and they provide short-term or titratable blockade

Why are competitive antagonists generally safer in overdose situations?

Because their antagonism can be reversed.

Why might a non-competitive antagonist be preferred?

When sustained inhibition and longer duration of action are desired.

Why are overdoses involving non-competitive antagonists more difficult to reverse?

Their effects persist despite high agonist concentrations.

What effect does naloxone have compared with opioid agonists?

Naloxone antagonizes opioid effects, reversing opioid-mediated actions

An antagonist causes a rightward shift of the agonist curve without changing Emax. What type of antagonist is it?

Competitive antagonist

An antagonist decreases Emax and cannot be overcome by increasing agonist concentration. What type of antagonist is it?

Non-competitive antagonist.

A physician increases the dose of an agonist and restores the full response. What type of antagonist was likely present?

A competitive antagonist

A drug irreversibly inactivates receptors. Which class of antagonist is this?

Non-competitive antagonist.

Which antagonist type primarily affects potency rather than efficacy?

Competitive antagonists. They increase EC50 while leaving Emax unchanged.

Which antagonist type primarily reduces efficacy?

Non-competitive antagonists. They decrease Emax.

What is the quickest way to distinguish competitive from non-competitive antagonists on an exam?

• Competitive antagonist: Same receptor site, reversible, can be overcome by more agonist, rightward parallel shift, Emax unchanged, EC50 increased.

• Non-competitive antagonist: Different site or irreversible binding, cannot be overcome by more agonist, Emax decreased, non-parallel/downward shift.